Zentek (NASDAQ:ZTEK) Shares Up 1.5% - What's Next?

Key Points

• Zentek Ltd. (NASDAQ:ZTEK) shares increased by 1.5% recently, with trading prices ranging from $0.86 to $0.89.
• The company reported negative earnings per share of ($0.01) and a revenue of $0.57 million last quarter, showing a negative net margin of 1,186.72%.
• Institutional investors hold 0.77% of Zentek's stock, with Two Sigma Securities LLC recently acquiring a stake valued at approximately $31,000.

Zentek Ltd. (NASDAQ:ZTEK - Get Free Report)'s share price was up 1.5% during mid-day trading on Tuesday . The stock traded as high as $0.89 and last traded at $0.88. Approximately 18,284 shares traded hands during trading, a decline of 47% from the average daily volume of 34,285 shares. The stock had previously closed at $0.86.

Zentek Stock Performance

The stock has a market cap of $79.58 million, a P/E ratio of -15.20 and a beta of 0.47. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.25 and a quick ratio of 1.00. The firm's 50-day moving average price is $1.07 and its 200-day moving average price is $1.17.

Zentek (NASDAQ:ZTEK - Get Free Report) last released its quarterly earnings data on Thursday, August 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $0.04 million for the quarter. Zentek had a negative net margin of 981.17% and a negative return on equity of 53.31%.

Institutional Investors Weigh In On Zentek

An institutional investor recently bought a new position in Zentek stock. Two Sigma Securities LLC bought a new stake in Zentek Ltd. (NASDAQ:ZTEK - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 33,128 shares of the company's stock, valued at approximately $31,000. Hedge funds and other institutional investors own 0.77% of the company's stock.

Zentek Company Profile

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.